Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS-driven AML

Journal:

Cell Metabolism

Published:

2026-01-29

DOI:

10.1016/j.cmet.2026.01.001

Affiliations:

7

Authors:

19

Go to article

Institutions	Authors	Share
Shanghai Xuhui Central Hospital, China	6.833333	0.36
Shanghai Academy of Experimental Medicine, China	6.833333	0.36
State Key Laboratory of Metabolic Dysregulation and Prevention and Treatment of Esophageal Cancer, China	1.333333	0.07
Shenzhen People’s Hospital, China	1.000000	0.05
Fudan University, China	1.000000	0.05
The First Affiliated Hospital, Zhejiang University School of Medicine, China	1.000000	0.05
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)	1.000000	0.05

Interested in Oncology and Carcinogenesis?